Communiqués Vaso Corporation

Actions

VASO

US92233F1021

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets Autres places de cotation 20:32:30 13/07/2026			Varia. 5j.	Varia. 1 janv.
0,1950 ^USD	-2,30%		+2,63%	+11,49%

15/05	Vaso Corporation publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
31/03	Vaso Corporation publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 décembre 2025	CI

Communiqués

15/05	Vaso Corporation Announces Financial Results for First Quarter of 2026	AQ
31/03	Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025	AQ
17/12	Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare	AQ
19/11	Vaso Corporation Announces Divestiture of Subsidiary	AQ
14/11	Vaso Corporation Announces Financial Results for Third Quarter of 2025	AQ
14/08/25	Vaso Corporation Announces Financial Results for Second Quarter of 2025	AQ
15/05/25	Vaso Corporation Announces Financial Results for First Quarter of 2025	AQ
31/03/25	Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024	AQ
13/01/25	Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors	AQ
16/12/24	Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025	AQ
14/11/24	Vaso Corporation Announces Financial Results for Third Quarter 2024	AQ
19/09/24	Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I	AQ
26/08/24	Vaso Corporation Announces Date Change for Its Stockholders Meeting	AQ
14/08/24	Vaso Corporation Announces Financial Results for Second Quarter 2024	AQ
07/08/24	Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4	AQ
15/05/24	Vaso Corporation Announces Financial Results for First Quarter 2024	AQ
01/04/24	Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023	AQ
08/12/23	Vaso : Business Combination with Achari Ventures Holdings Corp. I is Expected to Be Completed in First Quarter of 2024 - Form 8-K	PU
07/12/23	Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger	PR
03/04/23	VASO CORP : Change in Directors or Principal Officers (form 8-K)	AQ
31/03/23	VASO CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
14/11/22	VASO CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/09/22	Vaso : Change in Certifying Accountants - Form 8-K	PU
16/09/22	VASO CORP : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
15/08/22	VASO CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ